☆ 4.6 Article

Estimated glomerular filtration rate partially recovered in patients without Hypertriglyceridemia during Tenofovir disoproxil fumarate treatment

ANNALS OF MEDICINE (2023)

Related references

Note: Only part of the references are listed.

Article Urology & Nephrology

Elevated triglycerides and reduced high-density lipoprotein cholesterol are independently associated with the onset of advanced chronic kidney disease: a cohort study of 911,360 individuals from the United Kingdom

Misghina Weldegiorgis et al.

Summary: This observational study found that elevated TG levels and reduced HDL-C levels are independently associated with the onset of advanced CKD, while there is no evidence of association between TC or LDL-C levels and the development of CKD stages 4-5. Further research is needed to determine if the associations between TG and HDL-C and the development of CKD are causal.

BMC NEPHROLOGY (2022)

Add to Collection

Article Medicine, General & Internal

Dynamic changes of estimated glomerular filtration rate are conversely related to triglyceride in non-overweight patients

Si-Qi Liu et al.

Summary: This study found that dynamic changes in renal function were inversely related to triglyceride (TG) levels during TDF treatment in patients with chronic hepatitis B (CHB) and normal body mass index, while no significant correlation was observed in overweight patients.

WORLD JOURNAL OF CLINICAL CASES (2022)

Add to Collection

Article Gastroenterology & Hepatology

First-line therapies for hepatitis B in the United States: A 3-year prospective and multicenter real-world study after approval of tenofovir alefenamide

Calvin Q. Pan et al.

Summary: This study aimed to investigate the real-world outcomes of tenofovir alafenamide (TAF) compared with other first-line regimens for chronic hepatitis B (CHB). The results showed that patients on TAF achieved a higher proportion of hepatitis B virus (HBV) DNA <= 20 IU/ml and normalized alanine aminotransferase (ALT) levels at 24 months compared to patients on tenofovir disoproxil fumarate (TDF) therapy, with stable estimated glomerular filtration rates (eGFRs). However, a higher percentage of patients with eGFR < 60 ml/min/1.7 m(2) was observed in the TDF-treated group. These findings suggest that switching from TDF or entecavir to TAF may lead to an increased frequency of ALT normalization and potential clearance of viremia at the 24-month time point.

HEPATOLOGY COMMUNICATIONS (2022)

Add to Collection

Article Immunology

Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (TDF) Versus Efavirenz/Emtricitabine/TDF in Treatment-naive Adults With Human Immunodeficiency Virus Type 1 Infection: Week 96 Results of the Randomized, Double-blind, Phase 3 DRIVE-AHEAD Noninferiority Trial

Chloe Orkin et al.

Summary: The study on the drug doravirine (DOR) in treatment-naive adults with HIV infection showed excellent efficacy and tolerability of DOR compared to efavirenz (EFV) through week 96, with fewer adverse reactions.

CLINICAL INFECTIOUS DISEASES (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Positive association between the ratio of triglycerides to high-density lipoprotein cholesterol and diabetes incidence in Korean adults

Joungyoun Kim et al.

Summary: The study investigated the relationship between TG/HDL-C ratio and diabetes incidence in Korean adults. Results showed that higher TG/HDL-C ratio was significantly associated with an increased risk of new-onset diabetes in both men and women.

CARDIOVASCULAR DIABETOLOGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

The ratio of triglycerides to high-density lipoprotein cholesterol is associated with the risk of chronic kidney disease in Korean men

Joungyoun Kim et al.

Summary: Dyslipidemia is nephrotoxic and can lead to chronic kidney disease (CKD). Higher TG/HDL-C ratios are associated with an increased risk of CKD in men, while moderate levels may reduce CKD incidence in women.

LIPIDS (2021)

Add to Collection

Article Gastroenterology & Hepatology

Safety and Efficacy of 48 Weeks REP 2139 or REP 2165, Tenofovir Disoproxil, and Pegylated Interferon Alfa-2a in Patients With Chronic HBV Infection Naive to Nucleos(t)ide Therapy

Michel Bazinet et al.

GASTROENTEROLOGY (2020)

Add to Collection

Article Medicine, General & Internal

Lipidomics Reveals Reduced Inflammatory Lipid Species and Storage Lipids after Switching from EFV/FTC/TDF to RPV/FTC/TDF: A Randomized Open-Label Trial

Adrian Curran et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Add to Collection

Review Gastroenterology & Hepatology

An expert review on the use of tenofovir alafenamide for the treatment of chronic hepatitis B virus infection in Asia

Michael R. Charlton et al.

JOURNAL OF GASTROENTEROLOGY (2020)

Add to Collection

Article Immunology

Tenofovir alafenamide vs. tenofovir disoproxil fumarate: an updated meta-analysis of 14 894 patients across 14 trials

Victoria Pilkington et al.

AIDS (2020)

Add to Collection

Article Chemistry, Medicinal

The Effect of Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF) on Liver Enzymes, Glucose, and Lipid Profile

Nicola Squillace et al.

DRUG DESIGN DEVELOPMENT AND THERAPY (2020)

Add to Collection

Article Immunology

Renal safety of tenofovir alafenamide vs. tenofovir disoproxil fumarate: a pooled analysis of 26 clinical trials

Samir K. Gupta et al.

AIDS (2019)

Add to Collection

Article Infectious Diseases

Lipid profile and renal safety of tenofovir disoproxil fumarate-based anti-retroviral therapy in HIV-infected Chinese patients

Junyang Yang et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2019)

Add to Collection

Article Pediatrics

Impact of dyslipidemia on estimated glomerular filtration rate in apparently healthy children and adolescents: the CASPIAN-V study

Mohammad Moafi et al.

WORLD JOURNAL OF PEDIATRICS (2019)

Add to Collection

Article Immunology

Reversible effect on lipids by switching from tenofovir disoproxil fumarate to tenofovir alafenamide and back

Ana Milinkovic et al.

AIDS (2019)

Add to Collection

Review Biotechnology & Applied Microbiology

Therapeutic strategies for hepatitis B virus infection: towards a cure

Gregory C. Fanning et al.

NATURE REVIEWS DRUG DISCOVERY (2019)

Add to Collection

Article Medicine, General & Internal

Efficacy and safety of tenofovir disoproxil fumarate in Chinese patients with chronic hepatitis B virus infection A 2-year prospective study

Shuqin Zheng et al.

MEDICINE (2019)

Add to Collection

Article Infectious Diseases

Efficacy and safety of switching to dolutegravir plus emtricitabine/tenofovir disoproxil fumarate (TDF) or elvitegravir/cobicistat/emtricitabine/TDF in virologically suppressed HIV-infected patients in clinical practice: results from a multicentre, observational study

G. Baldin et al.

HIV MEDICINE (2019)

Add to Collection

Article Gastroenterology & Hepatology

96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection

Kosh Agarwal et al.

JOURNAL OF HEPATOLOGY (2018)

Add to Collection

Review Health Care Sciences & Services

Combined use of the Consolidated Framework for Implementation Research (CFIR) and the Theoretical Domains Framework (TDF): a systematic review

Sarah A. Birken et al.

IMPLEMENTATION SCIENCE (2017)

Add to Collection

Review Health Care Sciences & Services

Renal safety of tenofovir and/or entecavir in patients with chronic HBV monoinfection

Young-Mo Yang et al.

THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2017)

Add to Collection

Article Gastroenterology & Hepatology

Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year, Prospective, Real-World Study in France

Patrick Marcellin et al.

DIGESTIVE DISEASES AND SCIENCES (2016)

Add to Collection

Article Cardiac & Cardiovascular Systems

Association of the triglycerides to high-density lipoprotein cholesterol ratio with the risk of chronic kidney disease: Analysis in a large Japanese population

Kazuhiko Tsuruya et al.

ATHEROSCLEROSIS (2014)

Add to Collection

© Peeref 2019-2024. All rights reserved.